Brazil's National Health Surveillance Agency (Anvisa) has approved the drug Awiqli, produced by the pharmaceutical company Novo Nordisk, to treat adult patients with type 1 and 2 diabetes ...
Awiqli, a weekly insulin injection, will soon become available in Canada, which doctors say will 'make life easier' for people living with diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback